Florida 2024 - Prostate Cancer Facts & Statistics April 29, 2024 Download FLORIDA's 2024 Prostate Cancer Facts & Statistics SheetIncidence RatesGiven 100,000 Florida men, 97 will be diagnosed with prostate cancer in their lifetime.24,090 will be diagnosed this year.The state is ranked #46 in the country for prostate cancer incidences. Mortality Rates16.4 in every 100,000 men will die from prostate cancer in Florida2,800 men in the state, this year alone.The state is ranked #49 in the country for prostate cancer deaths. CDMRP Grants in FloridaYear Introduced: 1997Total Grants to Date: 77Total Grand Awards Through FY 2022**: $37.7MGrant RecipientYearAmountJacksonville Mayo Clinic and Foundation2021$2,024,412University Of South Florida Institution: H. Lee Moffitt Cancer Center and Research Institute2018$1,719,936University of Miami, Coral Gables2022$1,347,118 $1,272,102Mayo Clinic and Foundation, Jacksonville2022$1,190,974* Congressionally Directed Medical Research Programs **PCRP (Prostate Cancer Research Program) data for FY 2023 has not yet been posted CDC’s National Comprehensive Cancer Control Program (NCCCP) Funding in FloridaDisseminate appropriate prostate cancer education targeted to disparate population. Support high-quality prostate cancer research and the development of collaborative research networks across Florida. Increase outreach efforts to minority men to educate on prostate cancer risk reduction behaviors and informed decision making on prostate cancer screening. Increase healthcare provider utilization of the informed decision making process to address screening and treatment options for prostate cancer. Increase health communication and health education efforts to education the public, policy makers, and the healthcare sector about the major issues relating to prostate cancer. Raise awareness of survivorship needs. Increase healthcare professionals’ knowledge, skills, and practice to address prostate cancer prevention, diagnosis, treatment, rehabilitation, and support for prostate cancer, as well as improve access and appropriate utilization of high quality prostate cancer care. Although the value of PSA screening remains controversial, men who present for periodic health examinations should be made aware of the availability of PSA testing so that they can make informed decisions about their individual need for routine screening. Discussion should include the implications for treatment versus continued monitoring, if positive values are found. Downloadable Materials Prostate Cancer by Locations More for you
Download FLORIDA's 2024 Prostate Cancer Facts & Statistics SheetIncidence RatesGiven 100,000 Florida men, 97 will be diagnosed with prostate cancer in their lifetime.24,090 will be diagnosed this year.The state is ranked #46 in the country for prostate cancer incidences. Mortality Rates16.4 in every 100,000 men will die from prostate cancer in Florida2,800 men in the state, this year alone.The state is ranked #49 in the country for prostate cancer deaths. CDMRP Grants in FloridaYear Introduced: 1997Total Grants to Date: 77Total Grand Awards Through FY 2022**: $37.7MGrant RecipientYearAmountJacksonville Mayo Clinic and Foundation2021$2,024,412University Of South Florida Institution: H. Lee Moffitt Cancer Center and Research Institute2018$1,719,936University of Miami, Coral Gables2022$1,347,118 $1,272,102Mayo Clinic and Foundation, Jacksonville2022$1,190,974* Congressionally Directed Medical Research Programs **PCRP (Prostate Cancer Research Program) data for FY 2023 has not yet been posted CDC’s National Comprehensive Cancer Control Program (NCCCP) Funding in FloridaDisseminate appropriate prostate cancer education targeted to disparate population. Support high-quality prostate cancer research and the development of collaborative research networks across Florida. Increase outreach efforts to minority men to educate on prostate cancer risk reduction behaviors and informed decision making on prostate cancer screening. Increase healthcare provider utilization of the informed decision making process to address screening and treatment options for prostate cancer. Increase health communication and health education efforts to education the public, policy makers, and the healthcare sector about the major issues relating to prostate cancer. Raise awareness of survivorship needs. Increase healthcare professionals’ knowledge, skills, and practice to address prostate cancer prevention, diagnosis, treatment, rehabilitation, and support for prostate cancer, as well as improve access and appropriate utilization of high quality prostate cancer care. Although the value of PSA screening remains controversial, men who present for periodic health examinations should be made aware of the availability of PSA testing so that they can make informed decisions about their individual need for routine screening. Discussion should include the implications for treatment versus continued monitoring, if positive values are found.
Grant RecipientYearAmountJacksonville Mayo Clinic and Foundation2021$2,024,412University Of South Florida Institution: H. Lee Moffitt Cancer Center and Research Institute2018$1,719,936University of Miami, Coral Gables2022$1,347,118 $1,272,102Mayo Clinic and Foundation, Jacksonville2022$1,190,974
